InvestorsHub Logo
Followers 52
Posts 6521
Boards Moderated 3
Alias Born 01/02/2003

Re: Fangster post# 80251

Friday, 03/24/2023 9:31:02 PM

Friday, March 24, 2023 9:31:02 PM

Post# of 83094
FTC Releases Reports on Cigarette and Smokeless Tobacco Sales. This is a year old.
Cigarettes are roughly 190.2 billion a year
Smokeless tobacco sales 4.82 billion.
Smokeless tobacco manufacturers also reported selling $804.8 million of nicotine lozenges or nicotine pouches in 2021, not containing tobacco.

The global nicotine gum market is $1.56 billion in 2022

The global nicotine gum market is highly competitive with the presence of various regional and global players. Moreover, the market has the presence of many private label nicotine gum brands owing to growing demand. Companies make themselves competitive by expanding product offerings, and improving taste, flavors, functionality, and marketing activities. Key players in the market include GlaxoSmithKline plc, ITC Limited, Johnson & Johnson, British American Tobacco, Perrigo Company, Takeda Consumer Healthcare Company Limited, Fertin Pharma, Alchem International Pvt. Limited, Cipla Health Limited, Dr Reddy’s Laboratories among others.

Worthwhile, depends. What I posted is the Nic/gum market. CVSI is shooting for Nic/cbd. Unknown to me how that would play. I see, example only that Walgreens sells their own brand of Nic/gum , many flavors, at about 17cent to 25 cent per piece. If CVSI can make something that works, at the same price or close, and get a foot hold in the market place, then why not. There are a lot of private vendors in this space, so. But they first have to get the product past the phase 1 2 3, and develop a pipeline.

It would seem to me that if a person is looking for a way to stop, Just go with what works, what is cheapest and available, because it’s only for a short term period anyway. IMO
Bearish
Bearish